Proven Track Record
Numbers that speak for themselves.
Accredited Investor Profiles
Years of Experience
Campaigns Supported
Capital Raise Supported
Trusted by Industry Leaders
“Growth Turbine and Varun Sharma have been instrumental in supporting Land Invest Corp's capital raise, bringing a highly strategic and data-driven approach to investor outreach. Their team consistently generates strong, qualified interest.”
Randy Goldberg
CEO, Land Invest Corp
“Growth Turbine is by far the best fundraising agency we've worked with. Their deep understanding of investor behavior and compliance-first approach makes them the go-to partner for any serious capital raise.”
Ryan Pierce
Wefunder
“Working with Growth Turbine has been a great experience. They've been highly engaged, incredibly responsive, and consistently willing to go the extra mile to support our Crowdfunding raise.”
David Kirschbaum
REtokens INC
“Huge fan of Growth Turbine and the work they are doing. Their expertise in investor acquisition is unmatched, and they consistently deliver results that move the needle for issuers on our platform.”
Jonny Price
VP, Wefunder
“Growth Turbine has been an excellent partner for our issuers. Their data-driven approach and compliance-first mentality sets them apart from every other agency in this space.”
Hunter Nicholas
Issuance
“We value our relationship with Growth Turbine and look forward to continuing to work together. Their investor acquisition capabilities and platform expertise have been a real asset to our ecosystem.”
Ryan Zega
tZERO
“Partnering with Growth Turbine has helped us drive growth across our issuer base. Their team brings real expertise and a results-oriented mindset to every engagement.”
Paul Matiychuk
Dealmaker
“Varun at Growth Turbine is legit. The depth of knowledge, the hands-on execution, and the genuine care for client outcomes — that's what sets them apart in this space.”
Justin Renfro
Director, Wefunder
Why Healthcare Fundraising Is Different
Investors evaluate health deals through regulation, evidence, and payer realities—not just “innovation.”
Regulatory Pathway
FDA class, clearance route, and expected timelines.
Evidence Quality
Clinical data, outcomes, pilots, and validation studies.
Reimbursement & Economics
Who pays, pricing logic, and ROI for buyers.
Go‑to‑Market Execution
Sales cycle, stakeholders, and integration effort.
Risk & Claims Discipline
What can be said, and how it is documented.
Capital Use & Milestones
Clear links from dollars to regulatory and commercial steps.
Featured Case Studies
Your Health Tech, Pharma & Healthcare Investor Demand Plan
Optimal Raise Structure
Reg CF vs Reg D 506(c) vs Reg A+ based on stage and evidence.
Investor Audience Strategy
Targeting accredited investors, healthcare operators, and strategic‑aligned profiles.
Resonant Messaging
Clinical and technical detail turned into clear, underwritable messaging.
Compliant Funnel & Outreach
Funnels, qualification, and nurture that filter serious investors and stay claims‑safe.
What's Included in Our Healthcare Investor Acquisition System
A complete system for health tech, pharma, and healthcare raises.
Capital Strategy & Investor Positioning
- Align structure and terms to your evidence and timeline.
- Position your raise around clinical evidence, regulatory pathway, and stakeholder adoption.
- Tailor messaging to healthcare investor expectations around claims safety and compliance.
Compliant Funnel & Conversion Architecture
- Build claim‑safe funnels and qualification flows.
- Claims-safe funnels that surface serious investors through structured clinical screening.
- Qualification flows designed for healthcare diligence standards and regulatory sensitivity.
Investor Traffic & Outreach
- Targeted campaigns to reach the right healthcare investor profiles.
- Campaigns targeting investors with demonstrated interest in health tech, digital health, and medtech.
- Compliance-reviewed creative that avoids medical claims while demonstrating clinical value.
Investor Nurture & Engagement
- Sequences that answer questions on regulation, reimbursement, and evidence.
- Education sequences covering regulatory pathway, clinical validation, and reimbursement strategy.
- Objection handling for health tech concerns: FDA timeline, clinical adoption, and payer dynamics.
Reporting & Pipeline Intelligence
- Full‑funnel metrics on lead quality and performance.
- Pipeline analysis focused on investor clinical literacy and healthcare sector expertise.
- Optimization based on which evidence milestones and clinical proof points drive conversions.
Is Healthcare Investor Acquisition Right for You?
We work best with health tech, pharma, and healthcare teams that meet these criteria.
Strong Fit
- Have validation signals: pilots, data, adoption, revenue, or trial progress.
- Can clearly explain reimbursement and the economic buyer.
- Use proceeds tied to regulatory, clinical, and commercialization milestones.
- Want a compliance‑first investor engine that stands up to diligence.
Not a Fit
- No validation and no credible path to evidence.
- Unsupported claims or unrealistic timelines.
- Issuers unwilling to maintain compliance discipline.
- Teams seeking guaranteed raise results.
Frequently Asked Questions
Health tech investors prioritize clinical evidence, regulatory pathway clarity, and stakeholder adoption rates. They want validated outcomes, clear reimbursement strategy, and proof that clinicians, patients, or health systems are genuinely using the product. Strong health tech raises also demonstrate a defensible competitive position and realistic go-to-market timeline.
We build claims-safe messaging that clearly separates clinically validated outcomes from planned research. All creative goes through compliance review to avoid medical claims that could create regulatory or legal exposure. We emphasize evidence, milestones, and regulatory progress rather than unsubstantiated efficacy statements.
For larger raises targeting institutional and accredited healthcare investors, Reg D 506(c) is often the better framework. It allows general solicitation while requiring accredited investor verification. Reg CF can work for digital health tools with strong patient or clinician communities. The right structure depends on raise size, clinical stage, and investor audience.
We use clinical qualification flows and structured education to surface investors who understand healthcare economics and regulatory timelines. Each touchpoint progressively filters for seriousness by presenting clinical data, regulatory pathway details, and realistic timeline expectations. Investors who reach your calendar are informed and aligned with your stage.
Most health tech campaigns take 6–14 weeks to launch, depending on regulatory sensitivity, clinical complexity, and compliance review requirements. Campaigns involving medical device or pharmaceutical claims may require additional legal review cycles. We compress timelines by running content, compliance, and creative workstreams in parallel.
Sometimes, if the story is clear, milestones are defined, and the product has demonstrable user adoption. Digital health tools with strong clinician or patient engagement are good candidates. More complex raises or those targeting institutional investors often use Reg D 506(c) for accredited investor access and higher raise limits.
Which Regulation Is Right for Your Health Tech Raise?
Regulatory framework choice impacts both compliance requirements and investor audience.
| Feature | Reg CF | Reg D 506(c) | Reg A+ |
|---|---|---|---|
| Max Raise | $5M / 12 months | Unlimited | $75M / 12 months |
| Investor Type | Anyone (retail + accredited) | Accredited only | Anyone (retail + accredited) |
| Best For Health Tech | Digital health tools with patient/clinician communities | Larger raises targeting healthcare-focused accredited investors | Scaling health platforms seeking broad participation |
| Compliance Complexity | Moderate (plus clinical claims review) | Moderate-High | High (SEC qualification + clinical sensitivity) |
| Timeline to Launch | 8–12 weeks | 8–14 weeks | 3–6 months |
Explore Related Industries
Discover more industries where we help founders attract investors and raise capital.
Biotech Investor Acquisition
Attract investors for biotech innovations in drug discovery, diagnostics, and therapeutic development.
Learn moreAI & Machine Learning Investor Acquisition
Connect with investors backing AI-driven healthcare solutions, from diagnostics to drug design.
Learn moreEnvironment & Sustainability Investor Acquisition
Reach impact investors focused on sustainable health practices and environmental health innovation.
Learn more